1. Show article details.

    Kindred Announces Expansion of Its Home Health Operations and Growth in Four Integrated Care Markets

    Business Wire – 5:00 PM ET 02/09/2016

    Kindred Healthcare, Inc. (KND) today announced the expansion of its home health operations in South Carolina. Home Health – South Carolina Kindred acquired from the South Carolina Department of Health and Environmental Control licenses to provide home health services in all 46 counties in South Carolina for approximately $18 million.

  2. Show article details.

    Kindred’s Fourth Quarter Conference Call Scheduled for February 26

    GlobeNewswire – 4:30 PM ET 01/28/2016

    Kindred Healthcare, Inc. (KND) today announced that it will provide an online, real-time webcast of its conference call covering fourth quarter and year-end 2015 operating results on Friday, February 26, 2016.

  3. Show article details.

    PRESS DIGEST - Wall Street Journal - Jan 13

    Reuters – 12:33 AM ET 01/13/2016

    The following are the top stories in The Wall Street Journal. - Brewing giant Anheuser-Busch InBev SA is planning to sell roughly $30 billion in new bonds Wednesday in a deal that would rank as the second largest on record, underscoring the strength of the corporate-debt market despite turmoil in certain sectors.

  4. Show article details.

    Kindred to Pay $125 Million to Settle U.S. Suit

    DJ Business News – 3:15 PM ET 01/12/2016

    Kindred Healthcare Inc. (KND) agreed to pay $125 million to settle federal allegations it provided unnecessary therapy services to nursing-home patients as part of a scheme to overbill the federal Medicare program, according to the agreement finalized on Tuesday. Several nursing homes that hired Kindred's therapy unit, RehabCare, to provide services to their residents separately agreed to pay the federal government about $8 million for their role in the alleged scheme.

  5. Show article details.

    Kindred Healthcare to pay $125 million to settle government probe

    MarketWatch – 11:29 AM ET 01/12/2016

    Kindred Healthcare Inc. (KND) said on Tuesday it will pay $125 million, plus interest, to settle a Department of Justice investigation of its RehabCare Group Inc. unit. Kindred expects to make the payment during the first-quarter of 2016. The healthcare company had already recorded a loss reserve of $125 million related to the DOJ investigation, and has recorded an additional $2 million fourth-quarter loss reserve to cover additional costs. The settlement relates to allegations...

  6. Kindred Healthcare to pay $125 mln to settle DOJ investigation into RehabCare

    MarketWatch – 11:21 AM ET 01/12/2016
  7. Show article details.

    Kindred Announces Settlement with the United States Department of Justice over RehabCare Investigation

    Business Wire – 11:18 AM ET 01/12/2016

    Kindred Healthcare, Inc. (KND) today announced that it has entered into a settlement agreement with the United States Department of Justice regarding a previously disclosed investigation of RehabCare Group, Inc., a therapy services company acquired by the Company on June 1, 2011.

  8. Show article details.

    Kindred Healthcare in $125 mln settlement with U.S. govt

    Reuters – 11:13 AM ET 01/12/2016

    Kindred Healthcare Inc (KND) has agreed to pay $125 million to settle government allegations that it knowingly caused skilled nursing facilities to submit false claims to Medicare, the U.S. Department of Justice said on Tuesday.

  9. Show article details.

    Kindred to Present at the J.P. Morgan Healthcare Conference

    Business Wire – 5:00 PM ET 01/05/2016

    Kindred Healthcare, Inc. (KND) today announced that Benjamin A. Breier, President and Chief Executive Officer, will make a presentation regarding the Company at the 34th Annual J.P. Morgan Healthcare Conference in San Francisco, California, on Wednesday, January 13, 2016, at 9:30 a.m. Pacific Time / 12:30 p.m. The presentation is being audio webcast and can be accessed at the Company’s website at htt...

  10. Show article details.

    Kindred Appoints Joseph L. Landenwich as General Counsel and Corporate Secretary

    Business Wire – 4:30 PM ET 12/22/2015

    Kindred Healthcare, Inc. (KND) today announced the appointment of Joseph L. Landenwich as General Counsel and Corporate Secretary. Ms. Riedman has served as Kindred’s General Counsel since August 1999 and as Chief Diversity Officer since December 2010. Mr. Landenwich has served as co-General Counsel and Corporate Secretary since May 2012.

  11. Show article details.

    Kindred Appoints Peter K. Kalmey as President of Its Hospital Division

    Business Wire – 4:30 PM ET 12/21/2015

    Kindred Healthcare, Inc. (KND) today announced the appointment of Peter K. Kalmey as President of its Hospital Division, effective January 1, 2016. Mr. Kalmey succeeds Steven L. Monaghan, who is retiring from Kindred effective December 31, 2015. Mr. Kalmey has served as Chief Operating Officer of the Hospital Division since October 2013.

  12. Show article details.

    Kindred's Third Quarter Conference Call Scheduled for November 5

    GlobeNewswire – 5:00 PM ET 10/26/2015

    Kindred Healthcare, Inc. (KND) today announced that it will provide an online, real-time webcast of its conference call covering third quarter 2015 operating results on Thursday, November 5, 2015.

Page:

Today's and Upcoming Events

  • Feb
    25

    KND to announce Q4 earnings After Market (Confirmed)

  • Feb
    26

    KND Earnings Conference Call at 10:00 AM Listen

Past Events (last 90 days)

No events in the past 90 days

Data provided by Wall Street Horizon, Inc. © 2016

Technical Events

Technical Analysis

PROVIDED BY TRADING CENTRAL
As with all your investments through Fidelity, you must make your own determination whether an investment is appropriate for you. Fidelity is not recommending or endorsing this security by making it available to customers. You should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase. Before investing, you should read the prospectus, offering circular, indenture, or similar document carefully for a full description of the product, including its features and risks, to determine whether it is an appropriate investment for your investment objectives, risk tolerance, financial situation and other individual factors, and be sure to re-evaluate those factors on a periodic basis.

Performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore, you may have a gain or loss when you sell your shares.


Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Growth stocks can be more volatile than other types of stocks. Value stocks can continue to be undervalued by the market for long periods of time. Foreign securities are subject to interest-rate, currency-exchange-rate, economic, and political risks, all of which are magnified in emerging markets. Illiquidity is an inherent risk associated with investing in real estate and REITs. There is no guarantee the issuer of a REIT will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid. Closed-end funds can trade at a discount to their NAV. Shareholders of Master Limited Partnerships may be treated as partners for tax purposes. Partnerships issue a Schedule K-1 (Form 1065) rather than a Form 1099 form for tax purposes. It lists the partner's share of income, deductions, credits, etc. Speak with your tax advisor to determine how this may affect you. A royalty trust is a type of corporation, mostly in the United States or Canada, usually involved in oil and gas production or mining. Royalty trusts may have special tax treatment, so you should consult a tax advisor on the potential tax consequences of investing in them.

News, commentary and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended for research purposes to help self-directed investors evaluate many types of securities including, but not limited to common stocks, American Depository Receipts, Master Limited Partnerships, real estate investment trusts. traditional preferred stock, trust preferred securities, third-party trust certificates, convertible securities, mandatory convertible securities and other exchange-traded equity and/or debt securities. Criteria and inputs entered, including the choice to make security comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from its use.